Stratos Wealth Partners’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-506
| Closed | -$321K | – | 1469 |
|
|
2025
Q1 | $321K | Sell |
506
-115
| -19% | -$72.9K | ﹤0.01% | 1059 |
|
|
2024
Q4 | $442K | Sell |
621
-158
| -20% | -$113K | 0.01% | 990 |
|
|
2024
Q3 | $819K | Buy |
779
+108
| +16% | +$114K | 0.01% | 756 |
|
|
2024
Q2 | $705K | Buy |
671
+46
| +7% | +$48.3K | 0.01% | 776 |
|
|
2024
Q1 | $602K | Buy |
625
+202
| +48% | +$194K | 0.01% | 828 |
|
|
2023
Q4 | $372K | Sell |
423
-43
| -9% | -$37.8K | 0.01% | 989 |
|
|
2023
Q3 | $383K | Buy |
466
+106
| +29% | +$87.2K | 0.01% | 919 |
|
|
2023
Q2 | $259K | Buy |
360
+43
| +14% | +$30.9K | 0.01% | 1010 |
|
|
2023
Q1 | $260K | Buy |
317
+36
| +13% | +$29.6K | 0.01% | 932 |
|
|
2022
Q4 | $203K | Sell |
281
-13
| -4% | -$9.38K | 0.01% | 1044 |
|
|
2022
Q3 | $203K | Buy |
+294
| New | +$203K | 0.01% | 1018 |
|
|
2022
Q2 | – | Sell |
-535
| Closed | -$374K | – | 1285 |
|
|
2022
Q1 | $374K | Buy |
535
+16
| +3% | +$11.2K | 0.01% | 913 |
|
|
2021
Q4 | $328K | Sell |
519
-231
| -31% | -$146K | 0.01% | 970 |
|
|
2021
Q3 | $454K | Buy |
+750
| New | +$454K | 0.01% | 784 |
|
|
2020
Q3 | – | Sell |
-610
| Closed | -$380K | – | 1052 |
|
|
2020
Q2 | $380K | Buy |
+610
| New | +$380K | 0.01% | 693 |
|
|
2018
Q4 | – | Sell |
-31
| Closed | -$13K | – | 2121 |
|
|
2018
Q3 | $13K | Buy |
+31
| New | +$13K | ﹤0.01% | 2066 |
|
|
2018
Q2 | – | Sell |
-17
| Closed | -$6K | – | 2214 |
|
|
2018
Q1 | $6K | Sell |
17
-11
| -39% | -$3.88K | ﹤0.01% | 2554 |
|
|
2017
Q4 | $11K | Buy |
+28
| New | +$11K | ﹤0.01% | 2129 |
|
|
2017
Q3 | – | Sell |
-1,051
| Closed | -$516K | – | 954 |
|
|
2017
Q2 | $516K | Sell |
1,051
-1
| -0.1% | -$491 | 0.03% | 443 |
|
|
2017
Q1 | $408K | Buy |
+1,052
| New | +$408K | 0.02% | 480 |
|